Evidence map›Paper›PMID 37398142›Full record

ArticlebioRxiv : the preprint server for biology2023

Genetic background influences the 5XFAD Alzheimer's disease mouse model brain proteome.

Cheyenne D Hurst, Amy R Dunn, Eric B Dammer, Duc M Duong, Nicholas T Seyfried, Catherine C Kaczorowski, Erik C B Johnson

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Cheyenne D HurstGoizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30322 USA.
Amy R DunnThe Jackson Laboratory, Bar Harbor, ME 04609 USA.
Eric B DammerGoizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30322 USA.
Duc M DuongGoizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30322 USA.
Nicholas T SeyfriedGoizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30322 USA.
Catherine C KaczorowskiThe Jackson Laboratory, Bar Harbor, ME 04609 USA.
Erik C B JohnsonGoizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30322 USA.
Emory University · USJackson Laboratory · USUniversity of Michigan · US

Funding

Cell Type-Specific Proteins that Promote Resilience to Cognitive Aging and Alzheimer's Disease (Suppl)R01AG075818 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KACZOROWSKI, CATHERINE COOK · 2021 to 2025
$7.1M
Systems Genetics Analysis of Resilience to Alzheimers diseaseR01AG057914 · NIA · JACKSON LABORATORY · PI KACZOROWSKI, CATHERINE COOK · 2017 to 2021
$7.0M
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's diseaseR01AG061800 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Christopher A. Gaiteri, Jeremy H. Herskowitz · 2018 to 2026
$6.9M
Systems Genetics Analysis of Sex Differences in Alzheimer's DiseaseR01AG074012 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HARARI, OSCAR, HOHMAN, TIMOTHY J · 2021 to 2025
$6.2M
Systems Control of Normal Aging and Alzheimer's DiseaseR01AG054180 · NIA · JACKSON LABORATORY · PI KACZOROWSKI, CATHERINE COOK · 2017 to 2021
$4.4M
Gene x Environment Interactions in Hypothalamic Dysfunction in Alzheimer's DiseaseRF1AG059778 · NIA · JACKSON LABORATORY · PI KACZOROWSKI, CATHERINE COOK, O'CONNELL, KRISTEN M · 2018 to 2020
$4.3M
Brain Proteomic Network Analysis to Elucidate Mechanisms and Biomarkers for Alzheimer's DiseaseK08AG068604 · NIA · EMORY UNIVERSITY · PI JOHNSON, ERIK C.B. · 2020 to 2024
$762k
NIA NIH HHS K08 AG068604NIA NIH HHS R01 AG054180NIA NIH HHS R01 AG057914NIA NIH HHS R01 AG061800NIA NIH HHS R01 AG074012NIA NIH HHS R01 AG075818NIA NIH HHS RF1 AG059778
6 · The paper itself

Abstract

There is a pressing need to improve the translational validity of Alzheimer's disease (AD) mouse models. Introducing genetic background diversity in AD mouse models has been proposed as a way to increase validity and enable discovery of previously uncharacterized genetic contributions to AD susceptibility or resilience. However, the extent to which genetic background influences the mouse brain proteome and its perturbation in AD mouse models is unknown. Here we crossed the 5XFAD AD mouse model on a C57BL/6J (B6) inbred background with the DBA/2J (D2) inbred background and analyzed the effects of genetic background variation on the brain proteome in F1 progeny. Both genetic background and 5XFAD transgene insertion strongly affected protein variance in hippocampus and cortex (n=3,368 proteins). Protein co-expression network analysis identified 16 modules of highly co-expressed proteins common across hippocampus and cortex in 5XFAD and non-transgenic mice. Among the modules strongly influenced by genetic background were those related to small molecule metabolism and ion transport. Modules strongly influenced by the 5XFAD transgene were related to lysosome/stress response and neuronal synapse/signaling. The modules with the strongest relationship to human disease-neuronal synapse/signaling and lysosome/stress response-were not significantly influenced by genetic background. However, other modules in 5XFAD that were related to human disease, such as GABA synaptic signaling and mitochondrial membrane modules, were influenced by genetic background. Most disease-related modules were more strongly correlated to AD genotype in hippocampus compared to cortex. Our findings suggest that genetic diversity introduced by crossing B6 and D2 inbred backgrounds influences proteomic changes related to disease in the 5XFAD model, and that proteomic analysis of other genetic backgrounds in transgenic and knock-in AD mouse models is warranted to capture the full range of molecular heterogeneity in genetically diverse models of AD.

Indexed as

5XFADAlzheimer’s diseaseB6xD2Mouse modelsProteomicsTranslational

Identifiers

PMID37398142
PMCPMC10312637
OpenAlexW4380450176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.